193 related articles for article (PubMed ID: 18482991)
1. Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization.
Vetter I; Cheng W; Peiris M; Wyse BD; Roberts-Thomson SJ; Zheng J; Monteith GR; Cabot PJ
J Biol Chem; 2008 Jul; 283(28):19540-50. PubMed ID: 18482991
[TBL] [Abstract][Full Text] [Related]
2. The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway.
Vetter I; Wyse BD; Monteith GR; Roberts-Thomson SJ; Cabot PJ
Mol Pain; 2006 Jul; 2():22. PubMed ID: 16842630
[TBL] [Abstract][Full Text] [Related]
3. Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent manner.
Spahn V; Fischer O; Endres-Becker J; Schäfer M; Stein C; Zöllner C
Pain; 2013 Apr; 154(4):598-608. PubMed ID: 23398938
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol.
Vetter I; Wyse BD; Roberts-Thomson SJ; Monteith GR; Cabot PJ
Eur J Pain; 2008 May; 12(4):441-54. PubMed ID: 17826200
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential vanilloid type 1 channel may modulate opioid reward.
Nguyen TL; Kwon SH; Hong SI; Ma SX; Jung YH; Hwang JY; Kim HC; Lee SY; Jang CG
Neuropsychopharmacology; 2014 Sep; 39(10):2414-22. PubMed ID: 24732880
[TBL] [Abstract][Full Text] [Related]
7. Scaffolding by A-kinase anchoring protein enhances functional coupling between adenylyl cyclase and TRPV1 channel.
Efendiev R; Bavencoffe A; Hu H; Zhu MX; Dessauer CW
J Biol Chem; 2013 Feb; 288(6):3929-37. PubMed ID: 23264624
[TBL] [Abstract][Full Text] [Related]
8. Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance.
Bao Y; Gao Y; Hou W; Yang L; Kong X; Zheng H; Li C; Hua B
Int J Cancer; 2015 Sep; 137(6):1475-83. PubMed ID: 25708385
[TBL] [Abstract][Full Text] [Related]
9. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.
Avidor-Reiss T; Bayewitch M; Levy R; Matus-Leibovitch N; Nevo I; Vogel Z
J Biol Chem; 1995 Dec; 270(50):29732-8. PubMed ID: 8530363
[TBL] [Abstract][Full Text] [Related]
10. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
11. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DRG-TRPV1 upregulation in myocardial ischemia contributes to exogenous cardioprotection.
Xu S; Xu Y; Cheng X; Huang C; Pan Y; Jin S; Xiong W; Zhang L; He S; Zhang Y
J Mol Cell Cardiol; 2020 Jan; 138():175-184. PubMed ID: 31836538
[TBL] [Abstract][Full Text] [Related]
13. Differential opioid agonist regulation of the mouse mu opioid receptor.
Blake AD; Bot G; Freeman JC; Reisine T
J Biol Chem; 1997 Jan; 272(2):782-90. PubMed ID: 8995364
[TBL] [Abstract][Full Text] [Related]
14. Morphine inhibits acid-sensing ion channel currents in rat dorsal root ganglion neurons.
Cai Q; Qiu CY; Qiu F; Liu TT; Qu ZW; Liu YM; Hu WP
Brain Res; 2014 Mar; 1554():12-20. PubMed ID: 24491633
[TBL] [Abstract][Full Text] [Related]
15. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
16. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
[TBL] [Abstract][Full Text] [Related]
17. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.
Chen SR; Prunean A; Pan HM; Welker KL; Pan HL
Neuroscience; 2007 Mar; 145(2):676-85. PubMed ID: 17239544
[TBL] [Abstract][Full Text] [Related]
18. Orphanin FQ/nociceptin and mu-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway.
Wallington CL; Peters DM; Gelb CR; Peterfreund RA
Brain Res; 2002 Jul; 944(1-2):73-81. PubMed ID: 12106667
[TBL] [Abstract][Full Text] [Related]
19. Modulation of miR-139-5p on chronic morphine-induced, naloxone-precipitated cAMP overshoot in vitro.
Cao DN; Shi JJ; Wu N; Li J
Metab Brain Dis; 2018 Oct; 33(5):1501-1508. PubMed ID: 29916183
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to morphine at the mu-opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine.
Wang Z; Sadée W
Eur J Pharmacol; 2000 Feb; 389(2-3):165-71. PubMed ID: 10688980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
